A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit*

Abstract

Continuous sedation with dexmedetomidine results in significantly lower total intensive care unit costs compared with midazolam infusion for intensive care unit sedation, primarily due to decreased intensive care unit stay costs and reduced mechanical ventilation costs.